Abstract
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Issue: Jan/Feb 2023 - Volume 27, Number 1
Page(s): 53
						
							Download in electronic PDF format for $75
							
						
					
				Abstract
A formulation for preparing Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords
- erlotinib
 - formulations
 - oral suspensions
 - antineoplastic agent
 - epidermal growth factor receptor inhibitor
 - EGF receptor blocker
 - anticancer agent
 - cancer
 - tumor
 
Related Categories
- CANCER AND AIDS
 - EXCIPIENTS
 - FORMULATIONS
 - DOSAGE FORMS/DRUG CARRIERS